Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhao Peng

Showing results (41-50 of 403) with videos related to

Pageof 41
Sort By:
European Journal of Medicinal Chemistry|November 15, 2017
Recent advances in the discovery of potent and selective HDAC6 inhibitorsXiu-Xiu Wang, Ren-Zhong Wan, Zhao-Peng Liu
Current Medicinal Chemistry|March 11, 2014
Developments of kinesin spindle protein inhibitors as antitumor agents based on the five-membered heterocycle scaffoldsGuo-Dong Zhao, Ren-Zhong Wan, Zhao-Peng Liu
Archiv Der Pharmazie|May 29, 2014
Synthesis of sulfonylhydrazone- and acylhydrazone-substituted 8-ethoxy-3-nitro-2H-chromenes as potent antiproliferative and apoptosis inducing agentsDatong Zhang, Yuntong Ma, Yu Liu, et al.
Clinical and Experimental Pharmacology & Physiology|November 12, 2021
Hsp90 regulates the tumorigenic function of tyrosine protein kinase in osteosarcomaZhao-Peng Yao, Hui Zhu, Feng Shen, et al.
Quantitative Imaging in Medicine and Surgery|February 23, 2023
Percutaneous microwave ablation-induced pulmonary artery pseudoaneurysm: a case description and literature analysisJin-Zhao Peng, Zhi-Xin Bie, Xiao-Guang Li
Mini Reviews in Medicinal Chemistry|November 8, 2013
Recent developments of small molecule PI3K/mTOR dual inhibitorsYan-Na Liu, Ren-Zhong Wan, Zhao-Peng Liu
Expert Opinion on Therapeutic Patents|November 24, 2017
Evaluation of WO2017098421: GSK's benzothiazine compounds as CD73 inhibitor filingsYa-Ping Gong, Ren-Zhong Wan, Zhao-Peng Liu
Expert Opinion on Therapeutic Patents|August 4, 2018
Evaluation of WO2017018805: 1,3,4-oxadiazole sulfamide derivatives as selective HDAC6 inhibitorsYuan-Yuan Liang, Cheng-Mei Zhang, Zhao-Peng Liu
Acta Crystallographica. Section C, Crystal Structure Communications|December 7, 2005
Poly[strontium(II)-mu2-aqua-mu5-4-carboxylatophenoxyacetato]Zhao-Peng Deng, Shan Gao, Li-Hua Huo, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 3, 2011
Recent developments of small molecule EGFR inhibitors based on the quinazoline core scaffoldsYu-Jing Yu-Jing, Cheng-Mei Zhang, Zhao-Peng Liu
Pageof 41

Showing results (41-50 of 403) with videos related to

Sort By:
Pageof 41
European Journal of Medicinal Chemistry|November 15, 2017
Recent advances in the discovery of potent and selective HDAC6 inhibitorsXiu-Xiu Wang, Ren-Zhong Wan, Zhao-Peng Liu
Current Medicinal Chemistry|March 11, 2014
Developments of kinesin spindle protein inhibitors as antitumor agents based on the five-membered heterocycle scaffoldsGuo-Dong Zhao, Ren-Zhong Wan, Zhao-Peng Liu
Archiv Der Pharmazie|May 29, 2014
Synthesis of sulfonylhydrazone- and acylhydrazone-substituted 8-ethoxy-3-nitro-2H-chromenes as potent antiproliferative and apoptosis inducing agentsDatong Zhang, Yuntong Ma, Yu Liu, et al.
Clinical and Experimental Pharmacology & Physiology|November 12, 2021
Hsp90 regulates the tumorigenic function of tyrosine protein kinase in osteosarcomaZhao-Peng Yao, Hui Zhu, Feng Shen, et al.
Quantitative Imaging in Medicine and Surgery|February 23, 2023
Percutaneous microwave ablation-induced pulmonary artery pseudoaneurysm: a case description and literature analysisJin-Zhao Peng, Zhi-Xin Bie, Xiao-Guang Li
Mini Reviews in Medicinal Chemistry|November 8, 2013
Recent developments of small molecule PI3K/mTOR dual inhibitorsYan-Na Liu, Ren-Zhong Wan, Zhao-Peng Liu
Expert Opinion on Therapeutic Patents|November 24, 2017
Evaluation of WO2017098421: GSK's benzothiazine compounds as CD73 inhibitor filingsYa-Ping Gong, Ren-Zhong Wan, Zhao-Peng Liu
Expert Opinion on Therapeutic Patents|August 4, 2018
Evaluation of WO2017018805: 1,3,4-oxadiazole sulfamide derivatives as selective HDAC6 inhibitorsYuan-Yuan Liang, Cheng-Mei Zhang, Zhao-Peng Liu
Acta Crystallographica. Section C, Crystal Structure Communications|December 7, 2005
Poly[strontium(II)-mu2-aqua-mu5-4-carboxylatophenoxyacetato]Zhao-Peng Deng, Shan Gao, Li-Hua Huo, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 3, 2011
Recent developments of small molecule EGFR inhibitors based on the quinazoline core scaffoldsYu-Jing Yu-Jing, Cheng-Mei Zhang, Zhao-Peng Liu
Pageof 41